Home Applications 018613 Application 018613
Type NDA
Sponsor TARO PHARM INDS LTD Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 OVIDE MALATHION LOTION;TOPICAL 0.5% Yes No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N018613-001 OVIDE MALATHION 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** LOTION / TOPICAL RLD 1982-08-02
Orange Book patents# Current patent rows page 1 of 1 · 2 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N018613-001 7977324 2026-08-14 Drug product 2011-08-08 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 45 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N018613-001 OVIDE 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** LOTION / TOPICAL RLD 1982-08-02 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N018613-001 OVIDE 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** LOTION / TOPICAL RLD 1982-08-02 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N018613-001 OVIDE 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** LOTION / TOPICAL RLD 1982-08-02 e64feba35796…2022-07-09 03:26 UTC · 3 captures of this ZIP 2022-07 N018613-001 OVIDE 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** LOTION / TOPICAL RLD 1982-08-02 cb3db0bc1861…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N018613-001 OVIDE 0.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** LOTION / TOPICAL RLD 1982-08-02 a50c72e98297…
Observed Orange Book normalized TE history# Captured, Edition, Application-product table Captured Edition Application-product TE code Order Source SHA-256 2019-07-19 19:46 UTC 2019-07 N018613-001 AT 1 ea99ee380514…
Observed Orange Book patent history# Patent history page 1 of 3 · 90 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-11-14 07:37:17 2026-10 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 d4dbc9d85df4…2026-11-14 07:37:17 2026-10 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product d4dbc9d85df4…2026-10-15 13:18:30 2026-09 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 c2088c7a36db…2026-10-15 13:18:30 2026-09 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product c2088c7a36db…2026-09-14 22:38:34 2026-08 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 84e616aacf4f…2026-09-14 22:38:34 2026-08 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 84e616aacf4f…2026-08-18 06:07:40 2026-07 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 5c6f7cd8ea54…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N018613-001 7977324 2026-08-14 Drug product 2011-08-08 5d02ea3f76ae…2022-04-08 23:34 UTC 2022-04 N018613-001 7560445 2027-02-01 U-986 Drug substance, Drug product 5d02ea3f76ae…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 2 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 51672-5276 OVIDE MALATHION TARO PHARMACEUTICALS USA, INC. NDA Current 51672-5277 MALATHION MALATHION TARO PHARMACEUTICALS U.S.A., INC. NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 11250 SUPPL 2011-12-14 973 SUPPL 2011-12-14 15048 SUPPL 2003-04-16 11249 SUPPL 2003-04-04 20135 SUPPL 1999-04-30 20134 SUPPL 1999-04-30